The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: a randomized, placebo-controlled, double-blind, dose-ranging study. (June 2019) - Fraser, Graeme; Lederman, Samuel; Waldbaum, Arthur; Lee, Misun; Skillern, Laurence; Ramael, Steven